”Evolution of ipsilateral breast cancer decoded by proteogenomics”
Authors:
- Tommaso De MarchiTMTommaso De Marchi
- Paul Theodor PylPPPaul Theodor Pyl
- Martin SjöströmMSMartin Sjöström
- Susanne Erika ReinsbachSRSusanne Erika Reinsbach
- Sebastian DiLorenzoSDSebastian DiLorenzo
- Björn NystedtBNBjörn Nystedt
- Gyula PekarGPGyula Pekar
- Fredrik WärnbergFWFredrik Wärnberg
- Irma FredrikssonIFIrma Fredriksson
- Mårten FernöMFMårten Fernö
Preprint
Abstract
Ipsilateral breast tumor recurrence (IBTR) is a clinically important event, where an isolated in-breast recurrence is a potentially curable event but also associated with an increased risk of distant metastases and breast cancer death. It currently remains unclear if IBTRs are associated with molecular changes that can be explored as a resource for precision medicine strategies targeting locally recurring breast cancer. Here, we employed a recently developed proteogenomics workflow to analyze a cohort of 27 primary breast cancers and their matched IBTRs by whole genome sequencing, RNA sequencing, and mass spectrometry-based proteomics to define proteogenomic features of tumor evolution. Analysis of mutational signatures, copy number changes, and cancer specific mutations revealed a relationship with estrogen and progesterone receptor statuses and increased levels of genetic change. This in turn altered the re-programming of the transcriptome and proteome towards a recurring molecular disease phenotype with high replicating capacity and a higher degree of genomic instability possibly enhanced by high expression of APOBEC3B . In conclusion, this study defines how primary breast tumors differentially evolve into different ipsilateral recurrent malignancies depending on their key biomarker status, suggesting that further enhancing the genomic instability in some tumors could serve as an alternative treatment option.Keywords
This publication has 64 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Evidence for APOBEC3B mutagenesis in multiple human cancersNature Genetics, 2013
- The Proteomics Identifications (PRIDE) database and associated tools: status in 2013Nucleic Acids Research, 2012
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Classification of Ipsilateral Breast Tumor Recurrences After Breast Conservation Therapy Can Predict Patient Prognosis and Facilitate Treatment PlanningAnnals of Surgery, 2011
- Genomic instability in breast cancer: Pathogenesis and clinical implicationsMolecular Oncology, 2010
- Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motilityNature Cell Biology, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003